» Articles » PMID: 27521617

Systematic Optimization of an Engineered Hydrogel Allows for Selective Control of Human Neural Stem Cell Survival and Differentiation After Transplantation in the Stroke Brain

Overview
Journal Biomaterials
Date 2016 Aug 14
PMID 27521617
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Stem cell therapies have shown promise in promoting recovery in stroke but have been limited by poor cell survival and differentiation. We have developed a hyaluronic acid (HA)-based self-polymerizing hydrogel that serves as a platform for adhesion of structural motifs and a depot release for growth factors to promote transplant stem cell survival and differentiation. We took an iterative approach in optimizing the complex combination of mechanical, biochemical and biological properties of an HA cell scaffold. First, we optimized stiffness for a minimal reaction of adjacent brain to the transplant. Next hydrogel crosslinkers sensitive to matrix metalloproteinases (MMP) were incorporated as they promoted vascularization. Finally, candidate adhesion motifs and growth factors were systemically changed in vitro using a design of experiment approach to optimize stem cell survival or proliferation. The optimized HA hydrogel, tested in vivo, promoted survival of encapsulated human neural progenitor cells (iPS-NPCs) after transplantation into the stroke core and differentially tuned transplanted cell fate through the promotion of glial, neuronal or immature/progenitor states. This HA hydrogel can be tracked in vivo with MRI. A hydrogel can serve as a therapeutic adjunct in a stem cell therapy through selective control of stem cell survival and differentiation in vivo.

Citing Articles

Engineered biomaterials in stem cell-based regenerative medicine.

Zhu F, Nie G, Liu C Life Med. 2025; 2(4):lnad027.

PMID: 39872549 PMC: 11749850. DOI: 10.1093/lifemedi/lnad027.


Utilisation of High Molecular Weight and Ultra-High Molecular Weight Hyaluronan in Management of Glioblastoma.

Salagean A, Moldovan C, Slevin M Gels. 2025; 11(1).

PMID: 39852021 PMC: 11764969. DOI: 10.3390/gels11010050.


Dynamic Hydrogel-Based Strategy for Traumatic Brain Injury Modeling and Therapy.

He X, Lei M, Chen X, Xu F, Liu H, Wei Z CNS Neurosci Ther. 2025; 31(1):e70148.

PMID: 39788897 PMC: 11717553. DOI: 10.1111/cns.70148.


Bioactive Materials Facilitate the Restoration of Neurological Function Post Cerebral Ischemic Stroke.

Wang C, Sun C, Ding Z, Wu X, Liu K, Cao J Int J Nanomedicine. 2025; 19:14171-14191.

PMID: 39764188 PMC: 11701096. DOI: 10.2147/IJN.S493987.


A new evidence-based design-of-experiments approach for optimizing drug delivery systems with exemplification by emulsion-derived Vancomycin-loaded PLGA capsules.

Namdar A, Borhanzadeh T, Salahinejad E Sci Rep. 2024; 14(1):31164.

PMID: 39732761 PMC: 11682087. DOI: 10.1038/s41598-024-82496-3.


References
1.
Svendsen C, Bhattacharyya A, Tai Y . Neurons from stem cells: preventing an identity crisis. Nat Rev Neurosci. 2001; 2(11):831-4. DOI: 10.1038/35097581. View

2.
Kelly S, Bliss T, Shah A, Sun G, Ma M, Foo W . Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci U S A. 2004; 101(32):11839-44. PMC: 511061. DOI: 10.1073/pnas.0404474101. View

3.
Binder D, Scharfman H . Brain-derived neurotrophic factor. Growth Factors. 2004; 22(3):123-31. PMC: 2504526. DOI: 10.1080/08977190410001723308. View

4.
Couillard-Despres S, Winner B, Schaubeck S, Aigner R, Vroemen M, Weidner N . Doublecortin expression levels in adult brain reflect neurogenesis. Eur J Neurosci. 2005; 21(1):1-14. DOI: 10.1111/j.1460-9568.2004.03813.x. View

5.
Baffert F, Le T, Sennino B, Thurston G, Kuo C, Hu-Lowe D . Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling. Am J Physiol Heart Circ Physiol. 2005; 290(2):H547-59. DOI: 10.1152/ajpheart.00616.2005. View